Valuing the effects of sildenafil in erectile dysfunction - Strong assumptions are required to generate a QALY value

被引:7
作者
Freemantle, N [1 ]
机构
[1] Univ York, Ctr Hlth Econ, Med Evaluat Grp, York YO10 5DD, N Yorkshire, England
关键词
D O I
10.1136/bmj.320.7243.1156
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1156 / 1157
页数:2
相关论文
共 7 条
[1]   BACKGROUND MATERIAL FOR THE WORKSHOP ON QALYS - ASSUMPTIONS OF THE QALY PROCEDURE [J].
CARRHILL, RA .
SOCIAL SCIENCE & MEDICINE, 1989, 29 (03) :469-477
[2]  
DOLAN P, 1996, J HLTH EC, V15, P109
[3]   Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate [J].
Freemantle, N ;
Mason, J .
BRITISH MEDICAL JOURNAL, 1999, 318 (7196) :1480-1482
[4]  
Gold MR, 1996, COST EFFECTIVENESS H
[5]   Oral sildenafil in the treatment of erectile dysfunction [J].
Goldstein, I ;
Lue, TF ;
Padma-Nathan, H ;
Rosen, RC ;
Steers, WD ;
Wicker, PA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1397-1404
[6]   Cost utility analysis of sildenafil compared with papaverine-phentolamine injections [J].
Stolk, EA ;
Busschbach, JJV ;
Caffa, M ;
Meuleman, EJH ;
Rutten, FFH .
BRITISH MEDICAL JOURNAL, 2000, 320 (7243) :1165-1168
[7]  
YAMEY G, 1999, BRIT MED J, V319, P1222